Glaukos (NYSE: GKOS) shares preliminary Q4 and 2025 net sales data

Rhea-AI Filing Summary

Glaukos Corporation filed a current report describing new financial communications to the market. The company issued a press release with its preliminary, unaudited net sales results for the fourth quarter and full fiscal year ended December 31, 2025, and furnished this release as Exhibit 99.1. Glaukos also prepared an investor presentation, furnished as Exhibit 99.2, which it intends to use in meetings with investors and other stakeholders and make available on its investor relations website. The company notes that the information in these exhibits is being furnished rather than filed under securities laws, which affects how it is treated for legal liability and incorporation into other regulatory documents.

0001192448false00011924482026-01-132026-01-13

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

​

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): January 13, 2026

Glaukos Corporation

(Exact name of registrant as specified in its charter)

​

Delaware	​ ​ ​	001-37463	​ ​ ​	33-0945406
(State or other jurisdiction	​	(Commission	​	(I.R.S. Employer
of incorporation)	​	File Number)	​	Identification No.)

​

​

One Glaukos Way Aliso Viejo, California	​ ​ ​	92656
​	​	​
(Address of principal executive offices)		(Zip Code)

​

Registrant’s telephone number, including area code: (949) 367-9600

​

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	​ ​ ​	Trading Symbol	​ ​ ​	Name of each exchange on which registered:
Common Stock	​	GKOS	​	New York Stock Exchange

​

​

​

​

​

​

​

Item 2.02. Results of Operations and Financial Condition.

​

On January 13, 2026, Glaukos Corporation (the “Company”) issued a press release announcing its preliminary, unaudited net sales results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

​

The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing.

​

​

Item 7.01. Regulation FD Disclosure.

The Company intends to present the materials attached as Exhibit 99.2 to this Current Report on Form 8-K (the “Investor Presentation”) from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company’s website at http://investors.glaukos.com.

The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing.

​

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	​ ​ ​	Description
99.1	​	Press Release of Glaukos Corporation dated January 13, 2026
99.2		Investor Presentation, dated January 2026
104	​	Cover Page Interactive Data File (embedded within the Inline XBRL document)

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GLAUKOS CORPORATION (Registrant)
​	​
	By:	/s/ Alex R. Thurman
		Name:     Alex R. Thurman
		Title:       Senior Vice President & Chief Financial Officer

​

Date: January 13, 2026

​

​

FAQ

What did Glaukos (GKOS) disclose in this 8-K filing?

Glaukos disclosed that it released a press release containing its preliminary, unaudited net sales results for the fourth quarter and fiscal year ended December 31, 2025, and that it prepared an investor presentation for use with investors.

Which period do Glaukos' preliminary results in this filing cover?

The preliminary, unaudited net sales results cover the fourth quarter and fiscal year ended December 31, 2025.

Where can investors find the Glaukos preliminary results and presentation?

The preliminary results are in the press release furnished as Exhibit 99.1, and the related investor materials are in the Investor Presentation furnished as Exhibit 99.2, which Glaukos also plans to post on its investor relations website at http://investors.glaukos.com.

Is the information about Glaukos' net sales in this 8-K considered filed with the SEC?

No. Glaukos states that the information in Item 2.02, Item 7.01, Exhibit 99.1, and Exhibit 99.2 is being furnished, not filed, under the Exchange Act and Securities Act, unless specifically incorporated by reference elsewhere.

What exhibits are included with this Glaukos (GKOS) 8-K?

The exhibits are: Exhibit 99.1 Exhibit 99.2 Exhibit 104

Who signed this Glaukos current report and in what capacity?

The report was signed on behalf of Glaukos Corporation by Alex R. Thurman, who is the company’s Senior Vice President & Chief Financial Officer.